TEVJF News and Press, Teva Pharmaceutical Industries Ltd From 01/31/24

2024-01-31 11:50:06 ET Teva Pharmaceutical Industries Limited (TEVA) Q4 2023 Earnings Conference Call January 31, 2024 8:00 am ET Company Participants Richard Francis - President, Chief Executive Officer Eric Hughes - Executive Vice President, Global R&D, Chief M...

2024-01-22 19:45:34 ET Summary Catalyst Pharmaceuticals is a biopharmaceutical company specializing in treatments for rare neurological and epileptic disorders. The company's main products are Firdapse and Fycompa, which make up the majority of its revenue. The launch of Agamr...

2024-01-17 14:13:32 ET Summary Catalyst Pharmaceuticals, Inc. has one approved product and another about to be launched, but its market cap is low at $1.7bn. The company is facing a major patent challenge and has high expenses with no major data catalysts or pipeline molecules. ...

2024-01-09 12:34:10 ET Teva Pharmaceutical Industries Limited (TEVA) J.P. Morgan 42nd Annual Global Healthcare Conference January 08, 2024 11:15 AM ET Company Participants Richard Francis - President, CEO & Director Conference Call Participants Christophe...

2023-12-14 11:20:18 ET Summary A PDUFA date of September 18th, 2024 has been set by the FDA to review whether or not the tradipitant should be approved for gastroparesis. The global gastroparesis treatment market is projected to reach $7.19 billion by 2029. An sNDA for the rev...

2023-11-28 12:45:05 ET Teva Pharmaceutical Industries Limited (TEVA) 6th Annual Evercore ISI HealthCONx Conference November 28, 2023 08:20 AM ET Company Participants Richard Francis - President and Chief Executive Officer Eric Hughes - Executive Vice President, Globa...

2023-11-20 16:21:22 ET Summary Teva is an Israeli pharmaceutical company and the largest global generic manufacturer which suffered numerous challenges in recent years. The new management has a clear vision of how to deliver value to shareholders with the help of the company's str...

2023-11-08 12:48:09 ET Teva Pharmaceutical Industries (TEVA) Q3 2023 Earnings Conference Call November 8, 2023 8:00 AM ET Company Participants Ran Meir - Senior Vice President, Investor Relations Richard Francis - President and Chief Executive Officer, Member of the ...

2023-10-25 10:05:00 ET Summary Sound Shore Fund, Inc. is registered as a diversified, open-end management investment company. The investment objective of the Fund is growth of capital. Sound Shore Fund Investor Class and Institutional Class declined in Q3 2023, but still outperfor...

2023-09-11 12:50:27 ET Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 21st Annual Global Healthcare Conference 2023 Call September 11, 2023, 08:40 AM ET Company Participants Richard Francis - Chief Executive Officer Conference Call Participants ...